Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

When novelty is not enough.

Murphy MF.

Am Health Drug Benefits. 2008 Mar;1(2):29-33.

2.

Postapproval Development Options in COPD: A Case Study in Value-Based Healthcare Systems.

Murphy MF, Antonini P, Lai ZV.

Am Health Drug Benefits. 2011 Jan;4(1):19-23.

3.

A comparison by payor/provider type of the cost of dying among frail older adults.

Experton B, Ozminkowski RJ, Branch LG, Li Z.

J Am Geriatr Soc. 1996 Sep;44(9):1098-107.

PMID:
8790240
4.

Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety.

Blum AB, Shea S, Czeisler CA, Landrigan CP, Leape L.

Nat Sci Sleep. 2011 Jun 24;3:47-85. doi: 10.2147/NSS.S19649. Print 2011.

5.

Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors.

Fischer MA, Schneeweiss S, Avorn J, Solomon DH.

N Engl J Med. 2004 Nov 18;351(21):2187-94.

6.

Evolving provider payment models and patient access to innovative medical technology.

Long G, Mortimer R, Sanzenbacher G.

J Med Econ. 2014 Dec;17(12):883-93. doi: 10.3111/13696998.2014.965255. Epub 2014 Oct 8.

PMID:
25221929
7.

Methods for the comparative evaluation of pharmaceuticals.

Zentner A, Velasco-Garrido M, Busse R.

GMS Health Technol Assess. 2005 Nov 15;1:Doc09.

8.

Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study.

Law MR, Lu CY, Soumerai SB, Graves AJ, LeCates RF, Zhang F, Ross-Degnan D, Adams AS.

Clin Ther. 2010 Apr;32(4):729-41; discussion 716. doi: 10.1016/j.clinthera.2010.04.007.

9.

Physician payment 2008 for interventionalists: current state of health care policy.

Manchikanti L, Giordano J.

Pain Physician. 2007 Sep;10(5):607-26. Review.

10.

Expert consensus (SBC/SBHCI) on the use of drug-eluting stents: recommendations of the Brazilian society of interventional cardiology/ Brazilian society of cardiology for the Brazilian public single healthcare system.

Lima VC, Mattos LA, Caramori PR, Perin MA, Mangione JA, Machado BM, Coelho WM, Bueno RR.

Arq Bras Cardiol. 2006 Oct;87(4):e162-7. Review. English, Portuguese.

11.

Current issues in pharmaceutical reimbursement.

Fijalka S, Fye D, Johnson PE.

Am J Health Syst Pharm. 2008 Jan 15;65(2 Suppl 1):S11-26. doi: 10.2146/ajhp070620. Review.

PMID:
18192243
12.

Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.

Ryan R, Santesso N, Lowe D, Hill S, Grimshaw J, Prictor M, Kaufman C, Cowie G, Taylor M.

Cochrane Database Syst Rev. 2014 Apr 29;(4):CD007768. doi: 10.1002/14651858.CD007768.pub3. Review.

PMID:
24777444
13.

Medicaid prior authorization policies and imprisonment among patients with schizophrenia.

Goldman D, Fastenau J, Dirani R, Helland E, Joyce G, Conrad R, Lakdawalla D.

Am J Manag Care. 2014 Jul;20(7):577-86.

14.

IMRT (intensity modulated radiation therapy): progress in technology and reimbursement.

Young R, Snyder B.

Radiol Manage. 2001 Nov-Dec;23(6):20-6, 28, 30 passim; quiz 33-5.

PMID:
11793560
15.
16.

[Early achievements of the Danish pharmaceutical industry--8. Lundbeck].

Grevsen JV, Kirkegaard H, Kruse E, Kruse PR.

Theriaca. 2016;(43):9-61. Danish.

PMID:
27491172
17.

[Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].

Mittermayer R, Huić M, Mestrović J.

Acta Med Croatica. 2010 Dec;64(5):425-34. Croatian.

PMID:
21692267
18.
19.
20.

Beyond spinal manipulation: should Medicare expand coverage for chiropractic services? A review and commentary on the challenges for policy makers.

Whedon JM, Goertz CM, Lurie JD, Stason WB.

J Chiropr Humanit. 2013 Aug 28;20(1):9-18. doi: 10.1016/j.echu.2013.07.001. eCollection 2013 Dec.

Supplemental Content

Support Center